Erratum to: Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes (t2d): the carmelina randomised controlled trial. | Clin Kidney J;14(9): 2136, 2021 Sep. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Erratum to: Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes (t2d): the carmelina randomised controlled trial.

Wanner, Christoph; Cooper, Mark E; Johansen, Odd Erik; Toto, Robert; Rosenstock, Julio; McGuire, Darren K; Kahn, Steven E; Pfarr, Egon; Schnaidt, Sven; von Eynatten, Maximilian; George, Jyothis T; Gollop, Nicholas D; Marx, Nikolaus; Alexander, John H; Zinman, Bernard; Perkovic, Vlado.

Clin Kidney J ; 14(9): 2136, 2021 Sep.

Article in En | MEDLINE | ID: mdl-34476096

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Clin Kidney J Year: 2021 Document type: Article Country of publication: United kingdom

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Clin Kidney J Year: 2021 Document type: Article Country of publication: United kingdom